BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
138 hedge funds and large institutions have $32.7M invested in bluebird bio in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less call options, than puts
Call options by funds: $295K | Put options by funds: $492K
58% less capital invested
Capital invested by funds: $78.3M → $32.7M (-$45.6M)
Holders
138
Holding in Top 10
–
Calls
$295K
Puts
$492K
Top Buyers
| 1 | +$847K | |
| 2 | +$674K | |
| 3 | +$468K | |
| 4 |
Morgan Stanley
New York
|
+$235K |
| 5 |
Goldman Sachs
New York
|
+$207K |
Top Sellers
| 1 | -$6.29M | |
| 2 | -$2.09M | |
| 3 | -$1.84M | |
| 4 |
MIC
Maxi Investments CY
Limassol,
Cyprus
|
-$1.25M |
| 5 |
BL
Bleichroeder LP
New York
|
-$1.02M |